Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin

PURPOSE: We examined the outcome of patients with newly diagnosed acute promyelocytic leukemia (APL) treated with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) with or without gemtuzumab ozogamicin (GO) but without traditional cytotoxic chemotherapy. PATIENTS AND METHODS: From February 2...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Ravandi, Farhad, Estey, Eli, Jones, Dan, Faderl, Stefan, O'Brien, Susan, Fiorentino, Jackie, Pierce, Sherry, Blamble, Deborah, Estrov, Zeev, Wierda, William, Ferrajoli, Alessandra, Verstovsek, Srdan, Garcia-Manero, Guillermo, Cortes, Jorge, Kantarjian, Hagop
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2009
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4881307/
https://ncbi.nlm.nih.gov/pubmed/19075265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.6130
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items